InvestorsHub Logo
icon url

flipper44

07/19/19 2:02 AM

#236899 RE: flipper44 #236897

Edit:

The trial has gone on long enough, that if there were manufacturing changes back in the mid-10's, preclinical bridge studies, plus the restraint on unblinding the trial (akin to a clinical bridge study), has allowed the trial to provide ample evidence of similarity over the course of another four years -- even if the final result is somewhat superior.

icon url

hyperopia

07/19/19 12:28 PM

#236945 RE: flipper44 #236897

Thanks flipper. It certainly wasn’t my intention to drag up yet another issue has been rehashed exhaustively like so many others on this board.
icon url

alexander77

07/19/19 1:15 PM

#236954 RE: flipper44 #236897

Could DCVAX-L be considered as a cure for a specific subtype of GBM patients and for other subgroups as an effective treatment?